Medfusion¿ 4000 Syringe Infusion Pumps Medfusion¿ 4000 Syringe Infusion Pumps are designed for...

FDA Device Recall #Z-0540-2014 — Class II — November 22, 2013

Recall Summary

Recall Number Z-0540-2014
Classification Class II — Moderate risk
Date Initiated November 22, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Smiths Medical ASD, Inc.
Location Saint Paul, MN
Product Type Devices
Quantity 9560 (8601 US, 959 OUS)

Product Description

Medfusion¿ 4000 Syringe Infusion Pumps Medfusion¿ 4000 Syringe Infusion Pumps are designed for use in care areas for the administration of fluids requiring precisely controlled infusion rates. These pumps are indicated for use by healthcare professionals in the delivery of IV solutions, drug solutions, blood or blood products, and enteral feedings in continuous, intermittent, and body weight delivery modes.

Reason for Recall

Smiths Medical is conducting a recall involving all Medfusion¿ 4000 Syringe Infusion Pumps. Smiths Medical has identified an issue with electrical shorting at the AC power receptacle. Shorting can occur when saline solution or other conductive fluids (e.g., potassium chloride) enter the AC power receptacle. When this happens, sparking and/ or flames, accompanied by smoke, may appear at the AC po

Distribution Pattern

Worldwide Distribution - USA (nationwide ) including the states of : AZ, NY, TN, MS, AR, WV, VA, VT, PA, DE, DC, OH, CO, NH, MI, CA, FL, CT, WA, MD, NM, RI, MA, TX, NC, IL, KY, WI and MI., and the countries of CANADA, SAUDI ARABIA and AUSTRALIA.

Lot / Code Information

All Medfusion¿ 4000 Syringe Pumps in the field are affected by this Field Safety Corrective Action.

Other Recalls from Smiths Medical ASD, Inc.

Recall # Classification Product Date
Z-1667-2025 Class I CADD-Solis HPCA Ambulatory Infusion Pump; Mode... Apr 10, 2025
Z-1681-2025 Class I CADD-Solis Infusion Pump Models: 1) PUMP KIT,... Apr 10, 2025
Z-1668-2025 Class I CADD-Solis VIP Ambulatory Infusion Pump; Mode... Apr 10, 2025
Z-1662-2025 Class I CADD Solis HSPCA Pump Apr 10, 2025
Z-1682-2025 Class I CADD Solis VIP Ambulatory Infusion Pump Models:... Apr 10, 2025

Frequently Asked Questions

Contact your physician immediately if you use an electrical device or implant affected by this recall. For external devices (monitors, pumps), stop using the device and contact the manufacturer for a replacement. For implanted devices (pacemakers, ICDs), your cardiologist will assess whether you need device replacement surgery — the decision depends on how dependent you are on the device and the actual failure rate observed in the field. Do not attempt to repair or modify a recalled electrical medical device yourself. Monitor for any new or unusual symptoms and report them to your doctor.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.